Physiologically, it has been reported that stroke triggers the mobilization of CD105+ microparticles (regarded as MSC-EVs) and ischemia induces an increase in both circulating and regional levels of EVs [53], thereby leading to the hypothesized therapeutic relevance of MSC-EVs in stroke, and in particular, MSC-EVs obtained from low oxygen environments. This evidence concerns the gene ENG and ischemia.